Adjunctive vortioxetine for SSRI-resistant major depressive disorder: a “real-world” chart review study

OBJECTIVE: Selective serotonin reuptake inhibitors (SSRIs) are the cornerstone of treatment of major depressive disorder (MDD). However, non-response is common, often necessitating combination strategies. The present study assessed the efficacy of vortioxetine as an add-on therapy in patients with S...

Descripción completa

Detalles Bibliográficos
Autores principales: De Berardis, Domenico, Fornaro, Michele, Anastasia, Annalisa, Vellante, Federica, Olivieri, Luigi, Rapini, Gabriella, Serroni, Nicola, Orsolini, Laura, Valchera, Alessandro, Carano, Alessandro, Tomasetti, Carmine, Ventriglio, Antonio, Bustini, Massimiliano, Pompili, Maurizio, Serafini, Gianluca, Perna, Giampaolo, Iasevoli, Felice, Martinotti, Giovanni, Di Giannantonio, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Psiquiatria 2020
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236167/
https://www.ncbi.nlm.nih.gov/pubmed/32159712
http://dx.doi.org/10.1590/1516-4446-2019-0690

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236167/
https://www.ncbi.nlm.nih.gov/pubmed/32159712
http://dx.doi.org/10.1590/1516-4446-2019-0690

Ejemplares similares